Medicine Description Baraclude 0.5 mg
Baraclude 0.5 mg tablets is a medication that contains entecavir, a potent antiviral agent specifically designed to combat hepatitis B viral infections. Entecavir works by inhibiting the reverse transcriptase enzyme, which is crucial for the replication of the hepatitis B virus. By blocking this enzyme, entecavir effectively interrupts the viral life cycle, reducing the viral load in the body. This action leads to decreased viral replication and enhances liver function by alleviating liver inflammation and damage caused by the infection.
Indications and Uses of Baraclude 0.5 mg tablets
- Management of chronic hepatitis B infection in adults and pediatric patients.
- Use in patients with compromised liver function due to hepatitis B virus.
- Indicated for individuals with a history of resistance to antiviral drugs such as lamivudine or telbivudine.
Side Effects of Baraclude 0.5 mg tablets
- Fatigue or tiredness.
- Nausea and vomiting.
- Headaches.
- Dizziness.
- Diarrhea.
- Potential for liver-related side effects, including hepatic decompensation.
Storage and Handling
Baraclude tablets should be stored at room temperature, away from moisture and direct sunlight. Keep the medication out of reach of children and dispose of any unused tablets responsibly.
Patient Advice and Precautions
Patients should adhere strictly to the prescribed treatment regimen and attend regular follow-up appointments for liver function tests. It is essential to inform healthcare providers of any other medications being taken to avoid potential drug interactions. Patients should also be advised to maintain a healthy lifestyle, including proper nutrition and avoiding alcohol, to support liver health.